Reopening in April 2026
Early Career Research Fellowship
Total funding amount: Up to £65K across the entire fellowship.
Award duration: 1 year or longer if Less Than Full Time (LTFT). LTFT must be no less than 50% of the full-time equivalent.
Application deadline: 15 May 2026 (12:00 PM) (for expression of interest).
If you have questions about the fellowship or application process, please contact research@oruk.org.
We are investing in our future movement
As one of the few registered charities dedicated to addressing the most significant funding gaps in musculoskeletal (MSK) health research, we must continue to invest in the future of our field — and that future lies in supporting Early Career Researchers (ECRs). Strengthening the talent pipeline is essential if we are to generate the discoveries, innovations, and clinical impact that MSK health urgently requires.
Our focus is on supporting early career researchers who wish to pursue work within the activity areas defined in the UKCRC Health Research Analysis 2022. These areas represent the core foundations of MSK research and the greatest opportunities to create long‑term impact:
- Underpinning: understanding biological, psychological and socioeconomic processes.
- Aetiology: risks, causes and development of health conditions.
- Prevention: interventions to prevent disease, promote wellbeing and reduce risks of ill health.
- Detection and Diagnosis: population screening, using new diagnostic technologies and biomarker discovery and development.
- Treatment Development: translating basic research into experimental medicine in preclinical settings and/or model systems.
- Treatment Evaluation: testing and evaluating interventions in human clinical/applied settings.
- Disease Management: understanding patient needs and practitioner experiences.
- Health Services: examining healthcare at an organisational level, such as service provision and economic and policy issues.
Research with patients at its heart
The research we fund should aim to enhance the quality of life for people living with MSK conditions across joints, bones, muscles, or multiple body areas. Our priority is to back work that can move rapidly from ideas to practical solutions. By supporting Early Career Researchers, we aim to accelerate projects with the potential to transform clinical practice and improve outcomes at scale and at speed.
Impact can take many forms – from improving clinical processes and pathways to developing new products, tools, or services. What matters most is that the research has a credible path to real‑world benefit and the potential to positively influence the way clinicians work and how patients experience care.
The breadth of possible research topics include:
- AI / Big data / Digital technology / Computational modelling
- Cell, bone and soft tissue biology
- Biomaterials, biomechanics, prosthetic and surgical devices
- Hip
- Knee
- Osteoarthritis
- Pain
- Bone fractures
- Spine / Back
- Paediatric care
- Co-morbidity
- Foot & Ankle
- Shoulder
- Trauma and Orthopaedic surgery
- Bone cancer
- Rehabilitation & Exercise
- Hand & Wrist
- Rheumatic Arthritis
- Infection
- Fibromyalgia
- General MSK health awareness
The purpose of the fund
The Early Career Research Fellowship is designed to support the brightest and best clinical/nonclinical talents interested in advancing MSK research in the UK by:
- Funding of up to £65K over 1 year or longer if LTFT.
- Helping establish researchers’ academic independence and international reputation.
- Developing ambassadors for ORUK and supporting them to become future MSK leaders.
Who can apply?
- Early career clinical and non-clinical researchers, who are within eight years of their PhD award or equivalent professional training, or within six years of their first academic appointment, are invited to apply.
- Applicants within 6 months of PhD completion at the time of the ECR fellowship being awarded in December 2026 ( i.e. PhD completed by June 2027) will be considered.
Application process
Stage 1: Research Committee Review – Expression of Interest
The short expression of interest (EoI) form is designed to make the selection process at the early stage easier. The online form will allow researchers to convey the societal need for their research as clearly as possible.
No specific feedback will be generated at the end of this stage to either successful or rejected proposals other than confirming the decision of the Research Committee.
Please note that there will not be an appeal process in place to reverse the decision of the Research Committee. The EoI form must be submitted online.
Stage 2: External Expert Review – Full Application
The full application form will be emailed to the successful applicants after 15 June 2026.
All applicants are required to use scientific language and include images where appropriate, in addition to providing the necessary references to support their claims.
The applicants are encouraged to suggest up to five names of external experts within their research field to review their proposal. These external experts must not be linked to their application and ORUK will not guarantee that these individuals will be invited to review. More details can be found in our Conflicts of Interest policy.
Multiple external experts will be invited to review the full applications. External experts will be asked to use a scoring system to rate the scientific quality of research. At the end of this stage, applications will be ranked according to the scores received by the external experts. Those qualified or rejected at this stage will be notified via e- mail.
Applicants of the rejected proposals will receive their score along with any specific feedback that may have been provided by the external experts.
Those qualified at this stage will then be forwarded on to the Scientific Advisory Committee for further evaluation.
Accompanying their full application, the applicants are required to enclose CVs for all the stakeholders involved. The format of the files can be in both PDF (.pdf) or Word (.docx). For CVs, all files should be titled as following: “Name of researcher_CV.pdf”.
Stage 3: Scientific Advisory Committee Review
The Scientific Advisory Committee (SAC) normally meets up once a year to review and recommend the best MSK research that can make a positive impact on patients’ lives.
Applicants are required to appear before this committee, give a short presentation and take part in a Q&A session.
The same scoring system used by the external experts is applied to assess each application. Recommendations of the SAC will then be forwarded to the Board of Trustees.
Stage 4: ORUK Board of Trustees
The Board receives the recommendations of the SAC, and depending on the budget and additional information received, awards research grants and investments.
Assessment criteria
Applicants will be assessed on the following criteria and are also expected to provide details on Intellectual Property and testing on animals, if applicable.
- Purpose of research: research aims, objectives and deliverables.
- Background to investigation: brief literature review, personal track record and preliminary data obtained by the applicant(s).
- Plan of investigation, covering materials & methods: a detailed technical step-by-step research plan, according to linked work packages. and focusing on the core ideas and methodologies.
- Research environment and resources: research clinical/technical support, laboratory space, equipment and any other additional fundings.
- Research impact:
- Who will benefit from this research?
- How can your research be translated into care or treatment for patients?
- How will your research represent the aims and objectives of ORUK?
- Outreach and engagement.
- Research budget: full cost breakdown.
What are the key dates?
|
1 April 2026 |
Expressions of Interest (EoI) submissions open |
|
15 May 2026 (12:00) |
EoI submissions close |
|
18 May – 1 June 2026 |
Research Committee Review |
|
15 June 2026 |
EoI results announced, and full application submission opens. |
|
15 July 2026 (12:00 PM) |
Full application submission closes |
|
16 July – 30 October 2026 |
Expert Review |
|
November/December 2026 |
Scientific Advisory Committee (SAC) review |
|
December 2026 |
Final decisions by the Board of Trustees |
Recipient requirements
- Contract: The applicants must share the with their respective University /Trust’s Research Contracts Department and agree in principle with our Standard Research Agreement terms and conditions.
- Progress report: Every 6 months, the successful ORUK Fellows are asked to submit an interim report, covering their research progress and details of publications and presentations.
- Engagement: It is expected that the successful Fellows will support ORUK with public engagement, annual reports and publications, as well as fundraising campaigns (if any).
- The financial and non-financial support of ORUK must be duly acknowledged in all the presentations and publications by the Fellows.
Read more: Guidelines for grant holders.
How many fellowships will be funded?
Up to five (dependent on the quality and available budget).
How to apply
Expression of Interest (EoI) online application form
If you have questions about the fellowship or application process, please contact research@oruk.org.
Case studies
To Apply
Donate:
Help us continue funding research
The generosity of our donors will help us fund innovative research projects in the UK that expand knowledge, improve patient outcomes and pioneer new forms of orthopaedic treatment. Your support makes a real difference to the lives of millions of people suffering poor orthopaedic health, today and into the future.
DonateWhat our community has to say
Musculoskeletal tissue engineering
ORUK has been very supportive of a younger career researchers like me. It has been great to have people that put faith in you, rather than always going for the big groups and big universities. I would not be in the position I am now, has it not been for the support of ORUK.
Dr Jennifer Paxton
Senior Lecturer in Anatomy at the University of Edinburgh
Guiding sarcoma surgery
ORUK was the perfect partner for this project because it focuses on the treatment of people facing the most extreme musculoskeletal challenge – reducing the impact of orthopaedic surgery on sarcoma patients.
Mr Kenny Rankin
Consultant Orthopaedic Oncologist and Honorary Senior Lecturer at Newcastle University
Stem cell therapy
ORUK provides an invaluable source of research funding for those of us working within orthopaedics and especially those of us involved with smaller, but still valuable, research projects which can struggle to attract support from the larger funds. The MSK network represents an amazing opportunity, especially for academics like me to meet entrepreneurs and potential investors – to bounce ideas off each other and maybe even secure funding for our ideas.
Mr Vipin Asopa
Consultant Orthopaedic & Trauma Surgeon at South West London Elective Orthopaedic Centre